S. M. Ronnekleiv-Kelly

This study identifies CDK7 as a therapeutic target in fibrolamellar carcinoma by showing its activation in FLC cells and efficacy of CDK7 inhibitors in patient-derived models.

This study shows chronic jetlag accelerates pancreatic cancer in mice with Kras mutations by affecting fibroblasts rather than cancer cells directly.

This study shows that Pdx1 expression in hematopoietic cells of KC mice activates KrasG12D, leading to T-ALL and thymic tumors, with 20% of mice developing the disease by 9 months.